Skip to main content
2024 ASCRS Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
CME
CME
Invitation/Ticketed Event
Invitation/Ticketed Event
Invited Lectureship
Invited Lectureship
Award Recipient
Award Recipient
Live Streamed Session
Live Streamed Session
Nurses Contact Hours
Nurses Contact Hours
Self-Assessment
Self-Assessment
Back
Video ViewAttendees 29

Malignancy

APP Track
Symposium

Anal Dysplasia

Saturday, June 1, 2024
12:15 PM – 1:05 PM ET, USA
Location: Baltimore Convention Center, Room 307-310

CME Nurses Contact Hours Self-Assessment

    Co-Moderator(s)

  • Sandy Fang, MD

    Associate Professor
    Oregon Health and Sciences University
    Portland, Oregon, United States

    All relevant financial disclosures have been managed and will be listed below.
    Frantz Viral Therapeutics: Grant/Research Support (Terminated, June 30, 2021)

  • Joseph Terlizzi, MD

    Assistant Clinical Professor of Surgery
    Icahn School of Medicine at Mount Sinai
    New York, New York, United States

    All relevant financial disclosures have been managed and will be listed below.
    Frantz Viral Therapeutics: Clinical Trial Investigator (Ongoing); Merck and Co: Clinical Trial Investigator (Ongoing)

CME Credit: 0.75
Self-Assessment Credit: 0.75
Contact Hours: 0.75

The management of anal dysplasia is a rapidly evolving domain. This symposium is designed to bring practicing colorectal surgeons up to date with the latest literature and evidence. Experts participating in this symposium will discuss outcomes of the Anal Cancer/HSIL Outcomes Research (ANCHOR) trial, will explain cytology and pathology terminology relating to anal dysplasia, and will review difficult case studies to highlight important aspects of anal dysplasia screening.

Learning Objectives:

Upon completion of this activity, participants should be able to:
  • Explain the ANCHOR trial and describe the importance of treating anal high-grade squamous intraepithelial lesions.
  • Recognize cytology and pathology terminology related to anal dysplasia.
  • Demonstrate how experienced anoscopists perform high resolution anoscopy and manage patients with anal dysplasia.

Presentations:

  • 12:15 PM – 1:05 PM ET, USA
    Anal Dysplasia

    Co-Moderator: Sandy H. Fang, MD – Oregon Health and Sciences University

    Co-Moderator: Joseph Terlizzi, MD – Icahn School of Medicine at Mount Sinai

  • 12:15 PM – 12:18 PM ET, USA
    Introduction

    Speaker: Sandy H. Fang, MD – Oregon Health and Sciences University

    Speaker: Joseph Terlizzi, MD – Icahn School of Medicine at Mount Sinai

  • 12:18 PM – 12:29 PM ET, USA
    ANCHOR Trial: A Summary of the Study and Its Implications for Anal Dysplasia Screening

    Speaker: Joel Michael Palefsky, MD (he/him/his) – University of California, San Francisco

  • 12:29 PM – 12:40 PM ET, USA
    What Is My Pathologist Telling Me? A Review of Anal Cytology and Pathology Results Associated with Anal Intraepithelial Neoplasia

    Speaker: Beth-Ann Shanker, MD MSc (she/her/hers) – Trinity Hospital

  • 12:40 PM – 12:51 PM ET, USA
    HRA Technique/lesion Identification

    Speaker: Rebecca Levine, MD – Montefiore Medical Center/Albert Einstein College of Medicine

  • 12:51 PM – 1:01 PM ET, USA
    HSIL Treatment Options/technique

    Speaker: Julian Sanchez, MD (he/him/his) – Moffitt Cancer Center

  • 1:01 PM – 1:05 PM ET, USA
    Question and Answer